Stock Report

All about this stock under one free report Last Updated: 05-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Varex Imaging (VREX) Peer Comparison

Stock Card factsheet share-fund-plan-icon

$18.51

up-down-arrow $-0.02 (-0.08%)

As on 04-Sep-2026 13:36EDT

Market cap

info icon

$780 Mln

Revenue (TTM)

info icon

$865 Mln

P/E Ratio

info icon

34.9

P/B Ratio

info icon

1.6

Div. Yield

info icon

0 %

Edit peer-selector-edit
Varex Imaging (VREX) Penumbra (PEN) Glaukos Corp (GKOS) Bio-Rad Laboratories Repligen (RGEN)
Market cap ($ Mln)
 780 12,650 10,638 9,762 9,948
Revenue ($ Mln)
 865 1,505 613 2,589 785
Net Profit ($ Mln)
 22.10 160.59 -188.05 222.40 41.54
Net Margin (%)
 2.55 10.67 -30.68 8.59 5.29
RoE (%)
 4.50 10.86 -28.10 3.04 1.97
Price to Earnings
 34.91 79.29 -- 44.47 251.81
Price-To-Book
 1.57 8.31 15.27 1.36 4.86

Income Statement ($ Mln)

Varex Imaging (VREX) Penumbra (PEN) Glaukos Corp (GKOS) Bio-Rad Laboratories Repligen (RGEN)
Operating Revenue arrow
865.00 1,504.87 612.84 2,589.30 785.10
Cost of Revenue arrow
568.10 483.98 127.96 1,245.50 384.30
Gross Profit arrow
290.50 942.44 393.22 1,343.60 347.62
Operating Expenses arrow
224.70 833.56 565.37 1,108.90 335.50
Operating Profit (EBIT) arrow
72.20 187.34 -80.49 235.00 65.30
Other Income arrow
0.00 0.00 0.00 0.00 0.00
Profit before Tax arrow
27.70 203.83 -192.83 350.40 52.15
Provision for Tax arrow
5.20 43.24 -4.79 128.00 10.61
Profit after Tax (Net Income) arrow
22.10 160.59 -188.05 222.40 41.54
Minority Interest arrow
-0.20 0.00 0.00 0.00 0.00
Consolidated Profit arrow
0.00 93.19 0.00 0.00 0.00

Liabilities ($ Mln)

Varex Imaging (VREX) Penumbra (PEN) Glaukos Corp (GKOS) Bio-Rad Laboratories Repligen (RGEN)
Shareholder's Funds arrow
496.60 1,530.77 682.49 7,173.90 2,112.03
Minority Interest arrow
-0.20 0.00 0.00 0.00 0.00
Non-Current Liabilities arrow
402.10 210.18 135.71 2,116.80 705.49
Current Liabilities arrow
187.40 233.78 102.33 961.30 132.66
Total Liabilities arrow
1,107.40 1,826.52 893.49 10,576.50 2,949.70

Assets ($ Mln)

Varex Imaging (VREX) Penumbra (PEN) Glaukos Corp (GKOS) Bio-Rad Laboratories Repligen (RGEN)
Non-Current Assets arrow
446.80 630.60 404.74 7,231.50 1,749.63
Current Assets arrow
633.10 1,344.12 515.78 3,020.50 1,200.55
Total Assets arrow
1,107.40 1,826.52 893.49 10,576.50 2,949.70
Total Debt* arrow
373.60 212.71 102.84 1,203.70 690.94
Net Current Assets arrow
0.00 1,110.35 413.45 2,059.20 1,067.90

Cashflow ($ Mln)

Varex Imaging (VREX) Penumbra (PEN) Glaukos Corp (GKOS) Bio-Rad Laboratories Repligen (RGEN)
Cash From Operating Activities arrow
41.70 238.66 -46.34 532.20 117.42
Cash Flow from Investing Activities arrow
10.30 -404.59 -77.61 -189.70 -298.47
Cash from Financing Activities arrow
-75.90 26.53 11.89 -283.20 -15.21
Net Cash Inflow / Outflow arrow
-- -- -- -- --

Ratios

Profitability Ratios

 Varex Imaging (VREX) Penumbra (PEN) Glaukos Corp (GKOS) Bio-Rad Laboratories Repligen (RGEN)
ROCE (%) arrow
-7.48 11.76 -22.53 8.98 1.79
ROE (%) arrow
4.50 10.86 -28.10 3.04 1.97
ROA (%) arrow
1.48 7.95 -18.00 2.02 1.36
EBIT Margin (%) arrow
5.16 13.63 -30.58 -5.99 9.87
Net Margin (%) arrow
2.55 10.67 -30.68 8.59 5.29
Cash Profit Margin (%) arrow
0.00 0.00 0.00 0.00 0.00

Growth Ratios

 Varex Imaging (VREX) Penumbra (PEN) Glaukos Corp (GKOS) Bio-Rad Laboratories Repligen (RGEN)
Revenue Growth (%) arrow
5.31 17.55 41.55 1.37 16.49
EBIT Growth (%) arrow
224.93 17.49 -116.42 -131.06 920.91
Net Profit Growth (%) arrow
116.68 8.72 -102.66 -30.32 400.42
EPS Growth (%) arrow
116.07 8.12 -96.88 -29.66 394.30
Book Value Growth (%) arrow
6.25 17.33 -12.65 2.19 2.16

Valuation Ratios

 Varex Imaging (VREX) Penumbra (PEN) Glaukos Corp (GKOS) Bio-Rad Laboratories Repligen (RGEN)
Price / Earnings arrow
-7.37 68.93 -34.59 -- 189.42
Price / Book Value arrow
1.10 8.31 15.27 -- 4.40
Dividend Yield (%) arrow
-- 0.00 0.00 -- --
EV/EBITDA arrow
218.61 55.45 -73.80 -- 55.90
Market Cap ($ Cr) arrow
-- -- -- -- --

Solvency Ratios

 Varex Imaging (VREX) Penumbra (PEN) Glaukos Corp (GKOS) Bio-Rad Laboratories Repligen (RGEN)
Debt to Equity arrow
0.00 0.00 0.00 0.11 0.26
Short term debt to equity ratio arrow
0.05 0.01 0.00 0.06 0.01
Current Ratio arrow
3.38 5.75 5.04 3.14 9.05
Quick Ratio arrow
1.53 3.86 4.46 2.33 7.64
Interest Coverage arrow
1.71 157.91 -38.31 8.18 3.36

Operating Efficiency Ratios

 Varex Imaging (VREX) Penumbra (PEN) Glaukos Corp (GKOS) Bio-Rad Laboratories Repligen (RGEN)
Debtors to sales (%) arrow
16.73 12.65 22.67 17.06 20.09
Asset Turnover arrow
0.58 0.74 0.59 0.24 0.26
Receivable days arrow
68.13 46.54 60.95 65.39 72.41
Inventory Days arrow
185.95 331.92 193.84 221.09 146.53
Payable days arrow
42.52 26.16 60.19 37.02 29.05
Cash Conversion Cycle arrow
211.57 352.30 194.60 249.46 189.88
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...